ResearcherÜsküdar UniversityActive in the last 2 years

Nigar Kantarci-Carsibasi

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0003-1013-6668; OpenAlex author ID A5020239421. Sources: OpenAlex.

Their work

Papers: 1
Trials: 0
Grants: 0
Labs led: 0
Collaborators: 1

Papers, trials and grants by year

2025: 1 paper

Papers 1

In silico screening and in vitro biological evaluation reveal Queuine as a promising MAP4K4 inhibitor for treating pancreatic cancer. Co-author DOI 10.1186/s12896-025-01033-w ↗

Closest collaborators

The 1 strongest of 1 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

Shirin Tarbiat · 1 shared paper, 2025 · strength 0.33
- Paper In silico screening and in vitro biological evaluation reveal Queuine as a promising MAP4K4 inhibitor for treating panc… DOI 10.1186/s12896-025-01033-w ↗

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.